Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
BMC Neurology|April 21, 2021
Reduction in circulating vitamin D binding protein in patients with multiple sclerosisZhila Maghbooli, Abolfazl Omidifar, Tarlan Varzandi, et al.
Scientific Reports|July 2, 2025
The interplay between endoplasmic reticulum stress and inflammation in multiple sclerosisZhila Maghbooli, Forough Azam Sayahpour, Tarlan Varzandi, et al.
BMC Neurology|April 21, 2021
The possible role of Interleukin-6 as a regulator of insulin sensitivity in patients with neuromyelitis optica spectrum disorderZhila Maghbooli, Abdorreza Naser Moghadasi, Nasim Rezaeimanesh, et al.
Multiple Sclerosis and Related Disorders|May 17, 2024
Investigating the effects of 25-hydroxyvitamin D3 on clinical outcomes in multiple sclerosis patients: A randomized, double-blind clinical trial- a pilot studyZhila Maghbooli, Arash Shirvani, Abdorreza Naser Moghadasi, et al.
Life Sciences|June 14, 2018
Effect of long-term nitrite administration on browning of white adipose tissue in type 2 diabetic rats: A stereological studyTarlan Varzandi, Mahammad Amin Abdollahifar, Seyed Ali Haeri Rohani, et al.
Multiple Sclerosis and Related Disorders|August 7, 2022
Association between disease-modifying therapies and adverse clinical outcomes in multiple sclerosis patients with COVID-19 infectionZhila Maghbooli, Hesham Hosseinpour, Mohammad Reza Fattahi, et al.
Acta Neurologica Belgica|June 17, 2026
Correlation of serum glial fibrillary acidic protein (GFAP) and soluble triggering receptor expressed on myeloid cells-2 (sTREM-2) levels with disability and clinical characteristics in multiple sclerosisSanaz Khodadadi, Nasim Rezaeimanesh, Tarlan Varzandi, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 15, 2021
Treatment With 25-Hydroxyvitamin D3 (Calcifediol) Is Associated With a Reduction in the Blood Neutrophil-to-Lymphocyte Ratio Marker of Disease Severity in Hospitalized Patients With COVID-19: A Pilot Multicenter, Randomized, Placebo-Controlled, Double-Blinded Clinical TrialZhila Maghbooli, Mohammad Ali Sahraian, Saeidreza Jamalimoghadamsiahkali, et al.
Pageof 1